Last week, 5 Israeli firms were listed in the 2nd annual Digital Health 150 ranking, by New York-based research firm CB Insights. The list features the 150 most promising private digital health firms in the world.

Israel is amongst the 2020 Digital Health 150 cohort that highlights startups that are “reimagining” the lines of the traditional healthcare experience across twelve categories ranging from Online Care Delivery and Clinical Trials, to Drug Discovery & Specialty Care.

Israeli companies on the list are:

  • Zebra Medical Vision, an Artificial Intelligence powered medical imaging company that recently received its sixth FDA clearance for a mammography solution
  • IO, a medical technology startup that developed a smartphone-based urine albumin test that helps diagnose chronic kidney disease
  • TytoCare, a telehealth company that develops remote medical testing devices and recently raised $50 million
  • ai, a stroke detection platform that uses Artificial Intelligence to identify the source of a stroke in seconds
  • Nuvo Group, a firm commercializing a prescription started a remote pregnancy-monitoring platform cleared by the Food and Drug Administration.

The digital era creates numerous opportunities to revolutionize delivery of healthcare services to patients. For instance, patients can receive healthcare services anywhere, through any web or mobile device, without requiring a presence of healthcare provider. Moreover, Israeli Digital Health sector has long been using innovative communication technologies to enhance healthcare efficacy and delivery.

Other Innovative and interesting Israeli digital health companies include:

  • Koalys is a holistic Tele-Audiology Software as a Service platform for hearing care that provides means to perform hearing tests for screening, diagnostics, and hearing-aid fitting.
  • MobileODT develops software programs and optical diagnostic devices for early detection of cancer and numerous other medical purposes. The company has developed advanced optical technology components to turn smartphones into easy to use mobile point-of-care tools to help detect cancer. Additionally, this technology can also capture a range of biomedical images for diagnostic and different analytical purposes.
  • Elad Health is the developer of Chameleon, an electronic medical record (EMR) solution that enables tablets, PCs, and laptops connected to a wireless network to be used to deliver patient information. Chameleon provides a comprehensive medical view of the patient’s hospitalization processes as well as continuous interoperability across medical departments, units and clinics.
  • EyeControl is a medical device used in intensive care units. It uses pupil movements to allow bi-directional remote communication among ventilated patients and medical staff. Thus, enhancing accuracy of care, freeing up beds and equipment, and limiting contagion through decreasing the need for proximity.